Nippon Zoki Pharmaceutical


Nippon Zoki Pharmaceutical is committed to delivering optimal medical care by transcending the boundaries of a traditional pharmaceutical company. Since its founding in 1939, it has been dedicated to research and development, manufacturing, and sales of pharmaceuticals, focusing on open innovation and collaboration with partners to create new medical solutions and devices. The company aims to meet unmet needs of patients and healthcare professionals, contributing to society through continuous growth and innovation.

Industries

pharmaceutical

Nippon Zoki Pharmaceutical


Products

Prescription pharmaceuticals

A portfolio of prescription medicines across therapeutic areas, with associated clinical information and regulatory documentation.

Over-the-counter and quasi-drugs

Consumer-facing OTC medicines and quasi-drugs for common conditions (cold remedies, topical preparations, throat lozenges, etc.).

Medical devices (diagnostic/assessment and implants)

Clinical diagnostic/assessment devices (e.g., 3D back scanning systems) and orthopaedic implants such as spinal cages marketed for clinical use.

Regenerative-medicine investigational products

Investigational biomaterial products (e.g., nanofiber scaffolds) under clinical evaluation for tissue/nerve regeneration.

Consumer skincare and cosmetic products

Topical cosmetic and care products such as hand lotions intended for prevention of skin damage and general skin care.


Services

Medical information and consultation services

Telephone and email consultation services for healthcare professionals and consumers regarding pharmaceutical products and usage.

Licensing and partnership development

Identification, negotiation and management of in-licensing, out-licensing and co-development agreements for biologics and medical devices.

Clinical development and trial sponsorship

Sponsorship and operational oversight of clinical studies for regenerative-medicine and device candidates.

Expertise Areas

  • Pharmaceutical research and development
  • Regenerative medicine and biomaterials
  • Medical device development and commercialization
  • Clinical trial operations for biologics and devices
  • Show More (5)

Key Technologies

  • Nanofiber scaffold biomaterials for tissue/nerve regeneration
  • Bone morphogenetic protein (BMP) biologic development
  • Oncolytic virus therapeutic licensing (viral therapy platforms)
  • 3D surface back-scanning imaging for scoliosis screening
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.